Nature Medicine, Published online: 29 July 2026; doi:10.1038/s41591-026-04555-8
A new study reveals histidine as a readily measurable and potentially modifiable metabolic biomarker for cancer risk stratification and treatment optimization, but it also highlights the challenges of translating such associations into clinically usable interventions.
